Skip to main content
. 2022 Jun 13;30(3):473–482. doi: 10.5603/CJ.a2023.0018

Table 1.

Flecainide indication and contraindications.

Flecainide indications Flecainide contraindications
Atrial fibrillation/atrial flutter in patients who do not have structural heart disease
Pharmacological cardioversion of atrial fibrillation or flutter
Paroxysmal supraventricular tachycardia
Atrioventricular nodal re-entrant tachycardia
Atrioventricular re-entrant tachycardia
Wolff-Parkinson-White syndrome
Sustained ventricular tachycardia
Premature ventricular beats
Sustained fetal tachycardia (maternal/transplacental administration)
Ischemic heart disease
Hypertrophic cardiomyopathy
Hypertension with left ventricular hypertrophy
Congested heart failure
High-degree atrioventricular block
Complete bundle branch block
Structural heart disease
Sick sinus syndrome
Cardiogenic shock
Acquired/congenital QT prolongation with a history of torsades de pointes
Concurrent intake of ritonavir